Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/20095873

Download in:

View as

General Info

PMID
20095873